ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes (RUBY-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00994292
Recruitment Status : Completed
First Posted : October 14, 2009
Last Update Posted : October 19, 2015
Sponsor:
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Europe B.V. )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2011
  Actual Study Completion Date : March 2011
  Certification/Extension First Submitted : July 28, 2015